Mindwalk Holdings Corp. Stock
€0.97
Your prediction
Financial data and news for Mindwalk Holdings Corp.
sharewise wants to provide you with the best news and tools for Mindwalk Holdings Corp., so we directly link to the best financial data sources.
Financials
News
MindWalk Announces B Cell Llama(TM), a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era
Peer-reviewed study in ACS Biomacromolecules demonstrates modular VHH potency, cross-variant therapeutic activity, and a newly described immune-priming mechanism; MindWalk holds first right
MindWalk Applies HYFT® to Detect Functional Adjacency Risk in AI-Designed Therapeutics
AUSTIN, Texas – MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced an application of its
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease
14 January 2026 – VICTORIA, British Columbia – MindWalk Holdings Corp. (“MindWalk” or the “Company”) (Nasdaq: HYFT) today announced the discovery and validation of monoclonal antibodies and
MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
Validated Across Influenza A and Influenza B, Including H3N2 Subclade K and Zoonotic Influenza A Subtypes H5, H7, H9
AUSTIN, Texas – January 9th, 2026 - MindWalk Holdings Corp.